JP Morgan Initiates Sangamo BioSciences With Overweight By: Benzinga via Benzinga August 01, 2014 at 08:44 AM EDT Analysts at JP Morgan initiated coverage on shares of Sangamo BioSciences (NASDAQ: SGMO) with a Overweight rating. The target price ... Read More >> Related Stocks: Sangamo Therapeutics